Buys
Open market- Shares
- Avg price
- Total value
Neil Kumar - Chief Executive Officer, Director at BridgeBio Pharma, Inc.
Issuer-level insider activity
- Role
- Chief Executive Officer, Director
- Issuer ticker
- BBIO on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Neil Kumar in BridgeBio Pharma, Inc.
Sells
Open market- Shares
- -915,303
- Avg price
- $68.80
- Total value
- -$62,968,907
Net
Past year- Shares
- -915,303
- Share %
- -100%
- Total value
- -$62,968,907
Reported holdings for Neil Kumar in BridgeBio Pharma, Inc.
Form 4 holding
Chief Executive Officer, Director
BridgeBio Pharma, Inc.
- Security class
- Common Stock
- Shares / value
- 3,568,447
- Estimated value
- $265,777,932
- Report date
- 18 Aug 2026
- Price
- $74.48
- Ownership
- By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Form 4 holding
Chief Executive Officer, Director
BridgeBio Pharma, Inc.
- Security class
- Common Stock
- Shares / value
- 750,000
- Estimated value
- $55,860,000
- Report date
- 18 Aug 2026
- Price
- $74.48
- Ownership
- By NK 2026 GRAT
Form 4 holding
Chief Executive Officer, Director
BridgeBio Pharma, Inc.
- Security class
- Common Stock
- Shares / value
- 505,686
- Estimated value
- $43,312,005
- Report date
- 19 Aug 2026
- Price
- $85.65
- Ownership
- By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Form 4 holding
Chief Executive Officer, Director
BridgeBio Pharma, Inc.
- Security class
- Common Stock
- Shares / value
- 243,327
- Estimated value
- $20,384,281
- Report date
- 18 Aug 2026
- Price
- $83.77
- Ownership
- Direct
Form 4 holding
Chief Executive Officer, Director
BridgeBio Pharma, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 91,274
- Estimated value
- $6,023,201
- Report date
- 16 Aug 2026
- Price
- $32.58
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Executive Officer, Director
BridgeBio Pharma, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 40,570
- Estimated value
- Report date
- 17 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Neil Kumar in BridgeBio Pharma, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.